激情综合啪啪6月丁香,久久久久国产精品91福利,99精品日韩欧美在线观看,91成人午夜福利在线观看国产

上海瑞齊生物科技有限公司

Goat Anti-LY-6G/LY-6C(gr-1)

時(shí)間:2014-12-6閱讀:715
分享:

Goat Anti-LY-6G/LY-6C(gr-1)
Catalog Number :HZ209843 Quantity size : 0.1ml (dilute with pH 7.4
0.01 M PBS or antibody diluent )
Background: Ly6G is a GPI-anchored protein, that is also known as the myeloid
differentiation antigen Gr1. The antigen is transiently expressed on monocytes in the
bone marrow. The level of antigen expression in the bone marrow directly correlates
with granulocyte differentiation and maturation. Ly6G is expressed predominantly on
neutrophils, also in a subset of eosinophils, differentiating pre-monocytes, and
plasmacytoid dendritic cells.
pecificity :
– Anti-LY-6G/LY-6C(gr-1) is a Goat polyclonal antibody unconjugated.
– specific for LY-6G/LY-6C(gr-1) of rabbit
– use for western blotting,elisa,immunoprecipitation and immunohistochemistry
– Protein G affinity chromatography purification, purity :>95%
– Isotype: IgG
– mol wt: 30kDa
Application :
– Western blotting 1:100-500
– Immunohistochemistry 1:100-500
– ELISA 1:500-1000
– Optimal working dilutions must be determined by the end user.
Storage: Store at -20 ℃ for one year. Avoid repeated freeze/thaw cycles. The
lyophilized antibody is stable at room temperature for at least one month and for
greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M
PBS or diluent of antibody, the antibody is stable for at least six weeks at 2-4 ℃
Important Note: This product as supplied is intended for research use only, not for
use in human, therapeutic or diagnostic applications.

會(huì)員登錄

×

請(qǐng)輸入賬號(hào)

請(qǐng)輸入密碼

=

請(qǐng)輸驗(yàn)證碼

收藏該商鋪

X
該信息已收藏!
標(biāo)簽:
保存成功

(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

常用:

提示

X
您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~

以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),環(huán)保在線對(duì)此不承擔(dān)任何保證責(zé)任。

溫馨提示:為規(guī)避購(gòu)買風(fēng)險(xiǎn),建議您在購(gòu)買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。

在線留言
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |